About This Role As the Global S&OP & Long-Term Planning Lead, you will play a pivotal role in shaping how Biogen connects commercial strategy, supply chain planning, financial priorities, and long-term business growth. As part of
Shape the future of CRM by designing scalable Salesforce solutions across a global landscape. Act as the key link between business vision and technical execution in Sales & Marketing. Drive innovation, integration and transformation on a
What its about We are one of the largest global private markets investment managers, serving over 800 institutional investors worldwide. We have USD 185 billion in assets under management and around 2,000 professionals across 24 offices
Office Manager & Personal Assistant to the Director – 60% Employment: Part-Time, 60% Reports to: Director Driving Licence: Required Own Car: Strongly preferred Role Overview We are looking for a highly organised, proactive, trustworthy, and flexible
Global Marketing Director, Oncology Location: Zug - Switzerland, GSK HQ - London or Upper Providence - USA GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion
Company Description Sika is a specialty chemicals company with a globally leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protection in the building sector and industrial manufacturing.
Oncology Regional Area Lead – Fixed term 12 Months initially, potentially extendable to 18 months Location: Baar, Switzerland Working model: Hybrid, 50% office based and 50% field based Function: Commercial Excellence, Oncology Make an impact where
About The Role At Novocure, every role contributes to extending the lives of people living with cancer. As our new Clinical Quality Risk Management Lead , you’ll play a key part in this mission. The Clinical
Global Marketing Director, Oncology Location: Zug - Switzerland, GSK HQ - London or Upper Providence - USA GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion